AKT1 and neoplasm: ROS production especially during OXPHOS facilitates tumor progression in one aspect, such as by repressing tumor suppressor phosphatase and tensin homolog (PTEN) activity and subsequently enhancing phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt) pathway (Gorrini et al., 2013).